Peptide Safely
Some human studiesSleep

DSIP

Also called Delta sleep-inducing peptide, Emideltide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

A peptide first found in rabbits, hoped to deepen sleep, with mixed results in people.

Get DSIP ↗Plan my suppliesTested by Vertex Labs. We may earn a commission.
Typical dose25 nmol per kg (about 21 µg per kg, roughly 1,500 µg for a 70 kg adult)
How oftenOnce a day for 3–4 days
Half-lifeA few minutes in the blood (animal and human data)
Vial sizes2 mg, 5 mg

The simple version

What it does
It's meant to bring on deep sleep, but controlled trials found little effect.
How people take it
In trials, researchers gave about 1,500 µg by IV once a day for 3–4 days.
Know this
In placebo-controlled trials, it barely beat a placebo.

What it is

DSIP is a chain of nine amino acids that Swiss researchers found in 1977 in the blood of rabbits whose brains were stimulated to sleep, and it's named after the deep 'delta' stage of sleep. Nobody has clearly found a matching human gene, so scientists still argue about what it does in the body. It isn't approved as a medicine anywhere.

How it works

It's not well understood. Animal studies suggest it affects sleep patterns, stress hormones and your body clock, but it doesn't work like a sleeping pill with one clear target. It also breaks down quickly in the blood.

What people use it for

  • Insomnia and poor sleep
  • Deeper sleep (claimed)
  • Stress (claimed)
  • Opioid or alcohol withdrawal (old, small studies)

The evidence

Some human studies

Small 1980s studies by the Swiss team behind DSIP reported better sleep in people with chronic insomnia after IV shots, but those studies weren't blinded. When other groups ran placebo-controlled trials the effect was weak, and a Dutch study of 16 insomniacs found only small changes that may have been chance. There's no good modern research, and those studies didn't test the under-the-skin shots people use today.

How people dose it

Label doseFDA labelTrial doseclinical trialsReportedcommon use, untested

Insomnia trial dose (IV)

Trial dose
Dose
25 nmol per kg (about 21 µg per kg, roughly 1,500 µg for a 70 kg adult)
How often
Once a day for 3–4 days
When
Given in the afternoon or evening before sleep
Cycle
Short courses only (days)
Route
Intravenous injection (by researchers)

Why: This is the dose from double-blind insomnia trials (Monti 1987, Bes 1992). Those trials found little real benefit over placebo.

Common community use

Reported
Dose
100–300 µg
How often
Once a day, or only on nights when needed
When
30–60 minutes before bed
Cycle
1–2 weeks, then a break
Route
Subcutaneous injection

Why: A widely shared range that hasn't been tested in trials. People take it near bedtime because the blood clears it within minutes.

Start at the low end, and change one thing at a time. If you take medication or have a health condition, check with a doctor first.

Mix & measure

Set up for a 2 mg vial. Change any number to match yours. New to this? Read how to mix a vial and mg vs mL vs units first.

mg
mL
–

Plan your supplies

Pick your dose and how long you'll run it. We'll count what you need.

µg
–
We may earn a commission from these links. Counts include one syringe and two swabs per dose.

Stay safe

Side effects

  • Headache
  • Grogginess or vivid dreams
  • Nausea
  • Redness where you inject
  • Some users report worse sleep or no effect

Skip it if

  • Pregnant or breastfeeding
  • Sleep apnea or other untreated sleep problems (get checked first)
  • Taking other sleep medicines or sedatives without a doctor's advice

Interactions

  • May add to the effects of alcohol, sedatives, sleeping pills or opioids

Get help right away for swelling of the face or throat, trouble breathing, chest pain, or a spreading, hot, red injection site.

Storage & legal

Storage

Powder: fridge or freezer. Once mixed: fridge, use within about 2–3 weeks.

Legal status

FDA: Not approved. Emideltide (DSIP) was placed on FDA's compounding safety-concern list in 2023, then removed in April 2026 after the nomination was withdrawn. In July 2026 an FDA advisory committee voted 6 in favor and 7 against allowing it in compounding.

Sport (WADA): Not approved by any health authority, so it falls under WADA's S0 (non-approved substances): prohibited at all times.

Often paired with

Common questions

Will DSIP knock me out like a sleeping pill?

Unlikely. The best controlled trials found little or no difference from placebo.

Is it natural?

It was first found in rabbits, but its role in humans is unclear. What's sold is made in a lab.

What should I try first for insomnia?

Better sleep habits, treating snoring or apnea, and CBT for insomnia (a type of talk therapy) have far more evidence. See a doctor if poor sleep lasts more than a few weeks.

Sources

  1. Bes F, et al. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. Neuropsychobiology. 1992;26(4):193-7. PubMed 1299794
  2. Monti JM, et al. Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs. Int J Clin Pharmacol Res. 1987;7(2):105-10. PubMed 3583493
  3. Schneider-Helmert D. Efficacy of DSIP to normalize sleep in middle-aged and elderly chronic insomniacs. Eur Neurol. 1986;25(6):448-53. PubMed 3792404
  4. Schneider-Helmert D, et al. Synthetic delta-sleep-inducing peptide improves sleep in insomniacs. Lancet. 1981;1(8232):1256-7. PubMed 6112579
  5. US FDA. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Source

Last checked 2026-10